Related references
Note: Only part of the references are listed.994PDCLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) IN PATIENTS WITH HEAD & NECK SQUAMOS CELL CARCINOMA (HN-SCC)
A. Mahipal et al.
ANNALS OF ONCOLOGY (2017)
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P. Alberti et al.
ANNALS OF ONCOLOGY (2014)
Knockdown of CRM1 inhibits the nuclear export of p27Kip1 phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer
You Wang et al.
CANCER LETTERS (2014)
Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in spontaneous canine cancer: Results of phase I and phase II clinical trials
Cheryl A. London et al.
CANCER RESEARCH (2014)
Inhibition of Exportin 1 (XP01) potently suppresses growth of human neuroblastoma cell lines
Edward F. Attiyeh et al.
CANCER RESEARCH (2014)
A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway
Min Lu et al.
CELL (2014)
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
Ruben A. Mesa et al.
HAEMATOLOGICA (2014)
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
Giovanni Luca Gravina et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway
Naoya Saito et al.
MOLECULAR CANCER THERAPEUTICS (2014)
XPO1 ( CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
Yan Cheng et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study
Cheryl A. London et al.
PLOS ONE (2014)
Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts
Shuai Wang et al.
PLOS ONE (2014)
Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells
Jennifer Yang et al.
PLOS ONE (2014)
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models
Giovanni Luca Gravina et al.
PROSTATE (2014)
Nucleoporins and nucleocytoplasmic transport in hematologic malignancies
Akiko Takeda et al.
SEMINARS IN CANCER BIOLOGY (2014)
Atomic basis of CRM1-cargo recognition, release and inhibition
Ho Yee Joyce Fung et al.
SEMINARS IN CANCER BIOLOGY (2014)
Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer
Jiankun Gao et al.
ONCOTARGET (2014)
Redirecting traffic using the XPO1 police
Sheela A. Abraham et al.
BLOOD (2013)
Prognostic impact and targeting of CRM1 in acute myeloid leukemia
Kensuke Kojima et al.
BLOOD (2013)
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
Christopher J. Walker et al.
BLOOD (2013)
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
Julia Etchin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Therapeutic targeting of CRM1 in ovarian cancer
Takahito M. Miyake et al.
CANCER RESEARCH (2013)
KPT-330, a selective small molecule inhibitor of nuclear export, is active in bone and soft tissue sarcoma.
Jayasree S. Nair et al.
CANCER RESEARCH (2013)
Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
Xiaoguang Li et al.
CURRENT CANCER DRUG TARGETS (2013)
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
Giovanni Luca Gravina et al.
ENDOCRINE-RELATED CANCER (2013)
Selective Inhibitors of Nuclear Export Block Pancreatic Cancer Cell Proliferation and Reduce Tumor Growth in Mice
Asfar S. Azmi et al.
GASTROENTEROLOGY (2013)
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas
Asfar S. Azmi et al.
HAEMATOLOGICA (2013)
Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia
Juana Serrano-Lopez et al.
HAEMATOLOGICA (2013)
The dog as a possible animal model for human non-Hodgkin lymphoma: a review
Laura Marconato et al.
HEMATOLOGICAL ONCOLOGY (2013)
CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth
Hiromi Inoue et al.
JOURNAL OF UROLOGY (2013)
p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1
Aleixo Santiago et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
Roberto A. Salas Fragomeni et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
J. Etchin et al.
LEUKEMIA (2013)
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
J. Schmidt et al.
LEUKEMIA (2013)
CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas
Fang Zhou et al.
MEDICAL ONCOLOGY (2013)
Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis
Jin Long Liu et al.
PLOS ONE (2013)
Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
Qingxiang Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CRM1 Is a Cellular Target of Curcumin: New Insights for the Myriad of Biological Effects of an Ancient Spice
Mingshan Niu et al.
TRAFFIC (2013)
CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo
Joel G. Turner et al.
JOURNAL OF CANCER (2013)
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
Rosa Lapalombella et al.
BLOOD (2012)
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
Parvathi Ranganathan et al.
BLOOD (2012)
Selective inhibitors of nuclear export (SINE) activate multiple tumor suppressor pathways and kill prostate cancer cells across multiple genotypes in vitro and in vivo
Giovanni Luca Gravina et al.
CANCER RESEARCH (2012)
Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors
Ori Kalid et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro
Wei Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
Keiichi Sakakibara et al.
BLOOD (2011)
The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects
Laura Marconato
VETERINARY JOURNAL (2011)
Anti-influenza viral effects of novel nuclear export inhibitors from Valerianae Radix and Alpinia galanga
Ken Watanabe et al.
DRUG DISCOVERIES AND THERAPEUTICS (2011)
The cytotoxic styryl lactone goniothalamin is an inhibitor of nucleocytoplasmic transport
Jean-Yves Wach et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
BRCA1 16 years later: nuclear import and export processes
Marilyn E. Thompson
FEBS JOURNAL (2010)
Anguinomycins and Derivatives: Total Syntheses, Modeling, and Biological Evaluation of the Inhibition of Nucleocytoplasmic Transport
Simone Bonazzi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells
F. Zanella et al.
ONCOGENE (2010)
A critical role for the NFkB pathway in multiple myeloma
Yulia N. Demchenko et al.
ONCOTARGET (2010)
Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells
Kang-Seo Park et al.
CANCER LETTERS (2009)
Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
Joel G. Turner et al.
CANCER RESEARCH (2009)
Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
Sarah C. Mutka et al.
CANCER RESEARCH (2009)
The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
Pauline J. Van der Watt et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Nucleocytoplasmic Traffic of CPEB1 and Accumulation in Crm1 Nucleolar Bodies
Michele Ernoult-Lange et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
Aiguo Shen et al.
NEUROSURGERY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
Miguel F. Segura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
Aurelia Noske et al.
CANCER (2008)
CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
Joel G. Turner et al.
CURRENT MEDICINAL CHEMISTRY (2008)
FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells
A. N. Cornforth et al.
ONCOGENE (2008)
Involvement of FKHRL1 in melanoma cell survival and death
C. Hilmi et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Attenuated DNA damage repair by trichostatin a through BRCA1 suppression
Yin Zhang et al.
RADIATION RESEARCH (2007)
Topoisomerase II binds importin α isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells
Shelagh E. L. Mirski et al.
EXPERIMENTAL CELL RESEARCH (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Separating the anti-apoptotic and mitotic roles of survivin
Rita Colnaghi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Nuclear translocation and DNA-binding activity of NFKB (NF-κB) after exposure of human monocytes to pulsed ultra-wideband electromagnetic fields (1 kV/cm) fails to transactivate κB-dependent gene expression
M Natarajan et al.
RADIATION RESEARCH (2006)
Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity
HL Yang et al.
ONCOGENE (2005)
IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a
MCT Hu et al.
CELL (2004)
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
T Dohi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms
T Meissner et al.
FEBS LETTERS (2004)
Diastereoselective synthesis of 2,3,6-trisubstituted tetrahydropyran-4-ones via prins cyclizations of enecarbamates: A formal synthesis of (+)-ratjadone A
KN Cossey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells
T Imai et al.
ONCOGENE (2003)
Multi parameter in vitro testing of ratjadone using flow cytometry
A Burzlaff et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2003)
Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5
N Ohtani et al.
JOURNAL OF CELL BIOLOGY (2003)
Ratjadones inhibit nuclear export by blocking CRM1/exportin 1
M Köster et al.
EXPERIMENTAL CELL RESEARCH (2003)
Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs
Y Yashiroda et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression
BC Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Parc: A cytoplasmic anchor for p53
AY Nikolaev et al.
CELL (2003)
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export
D Daelemans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin
JA Rodríguez et al.
EXPERIMENTAL CELL RESEARCH (2002)
p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export
JR Alt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
JR Alt et al.
GENES & DEVELOPMENT (2000)
A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes
TT Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover
BR Henderson
NATURE CELL BIOLOGY (2000)
Share Paper
